Mounjaro®
Starting from £179.99/mo
Start journey Learn moreYes, Wegovy can make you sleepy, and fatigue is a recognised side effect listed in its prescribing information. Most people who notice tiredness on semaglutide find it strongest in the first few weeks of treatment or shortly after a dose increase, then it eases. It does not affect everyone, and it is rarely severe enough to stop treatment. These medicines are prescription-only, and a prescriber can help you work out whether tiredness is related to Wegovy or something else going on alongside it.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
When people say Wegovy makes them sleepy, they usually mean one of two things: a heavy, mid-afternoon fatigue that was not there before, or a general flatness that settles in during the first pen. Both are real, and both are worth taking seriously rather than pushing through without understanding the cause.
The NHS medicines page for semaglutide lists fatigue explicitly as a common side effect. In the STEP 1 clinical trial (68 weeks, 2.4mg weekly semaglutide versus placebo) tiredness was among the side effects reported by a meaningful minority of participants, concentrated in the early weeks. It tends to travel with the better-known gastrointestinal effects: nausea, reduced appetite, looser stools. When you are eating considerably less and your gut is working harder, your energy often takes a short-term hit.
There is also a practical explanation that gets overlooked. If Wegovy is doing its job and your appetite has dropped sharply, you may be eating far fewer calories than your body needs to function comfortably. Protein and fluid intake in particular can slip without much effort. That deficit alone produces fatigue regardless of the medicine's direct action. A question our prescribers hear most weeks is whether the tiredness you feel is a direct effect of semaglutide or something else entirely, often it is both, and untangling them matters.
The pattern is fairly predictable. Tiredness is most noticeable in the first two to four weeks at a new dose, then usually softens as your system adjusts. If your prescriber increases your dose (say from 1mg to 1.7mg) you may notice a similar, shorter dip in energy before it settles again. This mirrors the nausea curve: sharp early on, fading with time.
People who find the fatigue persists beyond a month at a stable dose should flag it. A prescriber can look at a few things: whether protein and hydration are adequate, whether sleep itself has changed (Wegovy's effects on hunger can disrupt normal evening eating routines and sleep quality), and whether any other cause needs ruling out. There is a broader picture of how Wegovy interacts with sleep patterns that is worth exploring if you are regularly waking tired.
There is no universal timetable, but most people who tolerate the GI side effects well also find their energy levels stabilise by weeks six to eight of each dose. If yours do not, that is a clinical conversation, not something to manage alone.
A few adjustments make a noticeable difference for many people. Keeping protein intake up (25 to 30 grams per meal is a reasonable target, though your prescriber or a dietitian should guide your personal plan) prevents the muscle-fatigue component. Drinking enough water matters more than usual because Wegovy-related nausea can reduce how much you want to eat or drink, and dehydration compounds tiredness significantly.
Timing your injection can help too. Some people find that taking it on a Thursday evening means any peak-effect tiredness lands over the weekend rather than mid-week. That said, the injection day should stay consistent once chosen; talk to your prescriber before shifting it.
The thing that tends not to help is caffeine-led compensation. Leaning on coffee to override fatigue when your body is signalling rest can disturb sleep and make the next day harder. It is also worth reading whether Wegovy affects sleep quality directly, because tiredness and poor sleep feed each other in ways that are easy to misattribute entirely to the medicine. If you are curious how the semaglutide molecule works more broadly, the semaglutide overview covers the mechanism behind it.
Ordinary start-up fatigue does not usually need urgent attention. But there are patterns that should prompt a call to your prescriber sooner. Severe tiredness that arrives alongside persistent nausea, stomach pain that spreads to your back, or yellowing of the skin or eyes needs same-day medical assessment, those symptoms together can point to gallbladder or pancreatic involvement, both of which are rare but recognised risks with GLP-1 medicines. The MHRA Yellow Card scheme is also there for anyone who wants to report a suspected side effect formally.
Fatigue that is unexplained, worsening or accompanied by low mood is also worth discussing with your GP separately from your weight-management prescriber. The two conversations are not mutually exclusive. If you are on Wegovy through a private clinic and do not have easy GP access, our support team is available seven days a week to help you work out the right next step.
For a more detailed look at why tiredness specifically crops up during semaglutide treatment, this page on feeling sleepy on Wegovy goes further into the physiology. And if you are weighing whether to start treatment and want to understand the full side-effect picture first, our clinical team is there to answer your questions during a free consultation, reviewed the same day by a real prescriber.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.